

18 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/18/3296554/0/en/provectus-biopharmaceuticals-reports-oral-pv-10-anti-tumor-activity-in-preclinical-bladder-cancer-study-long-term-survivors-show-absence-of-gross-bladder-tumor-at-study-end.html

02 Apr 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/04/02/3267302/0/en/Provectus-Biopharmaceuticals-Highlights-Preclinical-Evidence-of-PV-10-Mediated-Immune-Modulation-in-Burn-Wound-Healing-Porcine-Study-Demonstrates-Shift-Toward-Pro-Regenerative-Tiss.html

21 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/21/2885532/0/en/Provectus-Biopharmaceuticals-Announces-Poster-Presentation-of-Rose-Bengal-Sodium-for-Treatment-of-Full-Thickness-Cutaneous-Wounds-at-SID-2024-Annual-Meeting.html

02 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/02/2874159/0/en/Provectus-Biopharmaceuticals-Announces-Notice-of-Allowance-for-U-S-Patent-of-Oral-Administration-of-Rose-Bengal-Sodium-in-Hematology-Leukemia.html